Bristol Myers discloses patient death in early-stage cell therapy study

By Reuters News

- Bristol Myers Squibb BMY.N on Friday disclosed a patient death in an early-stage trial studying its experimental CAR T cell therapy.

Shares of the drugmaker were trading 2.5% lower in early trading.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk